Citation Impact
Citing Papers
Milatuzumab–SN-38 Conjugates for the Treatment of CD74+ Cancers
2013
Why Topical Retinoids Are Mainstay of Therapy for Acne
2017
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis
2016 Standout
Experimental models of traumatic brain injury: Do we really need to build a better mousetrap?
2005
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
2013 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Signaling via NF-κB in the nervous system
2005
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial
2006
Progressive Neurodegeneration After Experimental Brain Trauma
2013
Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?
2014
The Human Connectome Project and beyond: Initial applications of 300mT/m gradients
2013
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
NF-κB in the Survival and Plasticity of Neurons
2005
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging
2015 Standout
Long-Term Accumulation of Amyloid-β, β-Secretase, Presenilin-1, and Caspase-3 in Damaged Axons Following Brain Trauma
2004
Reflex control of immunity
2009 Standout
Alzheimer's disease
2006 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
NF-κB as a therapeutic target in neurodegenerative diseases
2007
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
2006 StandoutNobel
NF-κB: a key role in inflammatory diseases
2001 Standout
Moderate and severe traumatic brain injury in adults
2008 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Reactive oxygen species and the modulation of stroke
2005
NF-κB in neuronal plasticity and neurodegenerative disorders
2001
Traumatic injury to the immature brain: Inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets
2006
Early activation, motility, and homing of neonatal microglia to injured neurons does not require protein synthesis
2006
Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals
2014
Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat
2007
MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
2018
Delayed Increases in Microvascular Pathology after Experimental Traumatic Brain Injury Are Associated with Prolonged Inflammation, Blood–Brain Barrier Disruption, and Progressive White Matter Damage
2014
Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury
2015
Neuroinflammation: the devil is in the details
2016 Standout
Phytochemical and Botanical Therapies for Rosacea: A Systematic Review
2015
Magnesium in Man: Implications for Health and Disease
2014 Standout
Traumatic injury to the immature brain: Inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets
2006
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Interventions for rosacea
2015
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
IKK2/NF‐κB signaling protects neurons after traumatic brain injury
2017
Works of Matthew Leoni being referenced
Prolonged Activation of NF-κB Following Traumatic Brain Injury in Rats
1999
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies
2011
Acute treatment with MgSO4 attenuates long‐term hippocampal tissue loss after brain trauma in the rat
2004
Immediate coma following inertial brain injury dependent on axonal damage in the brainstem
2000
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
2015
Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea
2014
First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma
2008
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
2013
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.
2014
Reliability of Clinician Erythema Assessment grading scale
2014